DocGo (DCGO) director gets 150,000 RSUs vesting in December 2026 after board grant

Rhea-AI Filing Summary

DocGo Inc. director Michael J. Burdiek received 150,000 shares of restricted stock units on 12/12/2025. These units were granted under DocGo’s 2021 Stock Incentive Plan at a grant price of $0, meaning he does not pay cash to receive the shares when they vest.

The RSUs are scheduled to vest on December 12, 2026, as long as the award’s plan conditions are met. After this grant, Burdiek beneficially owns 791,560 shares of DocGo common stock in total, held directly.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Burdiek Michael J

(Last) (First) (Middle)

C/O DOCGO INC.

685 THIRD AVENUE, 9TH FLOOR

(Street)

NEW YORK NY 10017

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
DocGo Inc. [ DCGO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
12/12/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	12/12/2025		A		150,000(1)	A	$0	791,560	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents restricted stock units ("RSUs") granted pursuant to the Issuer's 2021 Stock Incentive Plan (the "Plan") that will vest on December 12, 2026, subject to the terms of the Plan. Each RSU represents the right to receive, upon vesting, one share of Common Stock, subject to the terms of the Plan.

Remarks:

	/s/ Jerilyn Laskie, as Attorney-in-Fact for Michael J. Burdiek	12/16/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did DocGo (DCGO) report for Michael J. Burdiek?

DocGo reported that director Michael J. Burdiek was granted 150,000 restricted stock units of DocGo common stock on 12/12/2025 at a grant price of $0.

When do Michael J. Burdiek’s new DocGo (DCGO) RSUs vest?

The 150,000 RSUs granted to Michael J. Burdiek are scheduled to vest on December 12, 2026, subject to the terms of DocGo’s 2021 Stock Incentive Plan.

How many DocGo (DCGO) shares does Michael J. Burdiek beneficially own after this grant?

Following the reported RSU grant, Michael J. Burdiek beneficially owns 791,560 shares of DocGo common stock, held in direct ownership.

What does each RSU granted to the DocGo (DCGO) director represent?

Each restricted stock unit granted to Michael J. Burdiek represents the right to receive one share of DocGo common stock upon vesting, under the 2021 Stock Incentive Plan.

Under which plan were the new DocGo (DCGO) RSUs granted to the director?

The 150,000 RSUs granted to Michael J. Burdiek were issued under DocGo’s 2021 Stock Incentive Plan, as described in the filing.

Is Michael J. Burdiek a director or officer at DocGo (DCGO)?

The report identifies Michael J. Burdiek’s relationship to DocGo as a Director, with the filing made by one reporting person.